Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent C O Njar

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Translational Cancer Research|January 8, 2019
Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapyVincent C O Njar
Expert Opinion on Therapeutic Targets|July 19, 2016
Letter to the editorVincent C O Njar
Steroids|October 10, 2012
A new simple and high-yield synthesis of 5α-dihydrotestosterone (DHT), a potent androgen receptor agonistPuranik Purushottamachar, Vincent C O Njar
Prostate Cancer|November 24, 2011
New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancerAbhijit M Godbole, Vincent C O Njar
Bioorganic & Medicinal Chemistry|June 5, 2007
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug developmentRobert D Bruno, Vincent C O Njar
Future Medicinal Chemistry|March 24, 2011
Novel, potent anti-androgens of therapeutic potential: recent advances and promising developmentsTadas S Vasaitis, Vincent C O Njar
Journal of Medicinal Chemistry|January 16, 2015
Discovery and development of Galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancerVincent C O Njar, Angela M H Brodie
The Journal of Steroid Biochemistry and Molecular Biology|August 3, 2016
Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targetsSenthilmurugan Ramalingam, Vidya P Ramamurthy, Vincent C O Njar
The Journal of Steroid Biochemistry and Molecular Biology|November 25, 2010
CYP17 inhibitors for prostate cancer therapyTadas S Vasaitis, Robert D Bruno, Vincent C O Njar
Cancer Research|December 6, 2006
Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cellsAashvini Belosay, Angela M H Brodie, Vincent C O Njar
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Translational Cancer Research|January 8, 2019
Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapyVincent C O Njar
Expert Opinion on Therapeutic Targets|July 19, 2016
Letter to the editorVincent C O Njar
Steroids|October 10, 2012
A new simple and high-yield synthesis of 5α-dihydrotestosterone (DHT), a potent androgen receptor agonistPuranik Purushottamachar, Vincent C O Njar
Prostate Cancer|November 24, 2011
New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancerAbhijit M Godbole, Vincent C O Njar
Bioorganic & Medicinal Chemistry|June 5, 2007
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug developmentRobert D Bruno, Vincent C O Njar
Future Medicinal Chemistry|March 24, 2011
Novel, potent anti-androgens of therapeutic potential: recent advances and promising developmentsTadas S Vasaitis, Vincent C O Njar
Journal of Medicinal Chemistry|January 16, 2015
Discovery and development of Galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancerVincent C O Njar, Angela M H Brodie
The Journal of Steroid Biochemistry and Molecular Biology|August 3, 2016
Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targetsSenthilmurugan Ramalingam, Vidya P Ramamurthy, Vincent C O Njar
The Journal of Steroid Biochemistry and Molecular Biology|November 25, 2010
CYP17 inhibitors for prostate cancer therapyTadas S Vasaitis, Robert D Bruno, Vincent C O Njar
Cancer Research|December 6, 2006
Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cellsAashvini Belosay, Angela M H Brodie, Vincent C O Njar
Pageof 7